Published May 2, 2018 This content is archived.
University at Buffalo School of Pharmacy and Pharmaceutical Sciences Clinical Research Program students presented defenses for their theses on May 2.
The third- and fourth-year students prepared their defenses in the style of the 3-minute thesis, which was founded by the University of Queensland, Australia.
The Clinical Research Program (CRP) is an opportunity for third and fourth year PharmD students to elevate themselves for placement in fellowships and residencies via individualized research programs focused on excellent original clinical and translational research. The CRP has a proven track record of providing students robust didactic and experiential clinical research activities which prepares them to compete for competitive post graduate training positions.
Abby Fornes | Phenotyping Bariatric Surgery Candidates: Optimizing the Answer to Bariatric Surgery Failure |
Amy Drzewiecki | What’s in a Name: The Rising Costs Associated with Utilizing Branded Diabetes Products |
Arthur Chan | Beauty and the Beast: a MCR-1 mixing experiment |
Nick Bosso | A World View: Travel Health recommendations for PharmD students during Global Health Experiences |
Cody Racha | Comprehensive Diabetes Interventions Between a Third-Party Payer and Local Community Pharmacies: An Outcomes Analysis |
Dominick Varis
| Response to Erythropoiesis Stimulating Agent Therapy in ESRD Patients Receiving Dialysis During Transitions of Care: A Retrospective Cross-Sectional Cohort Study |
Erik Novak | Antibody distribution in tumor tissue: overcoming barriers in pharmacokinetics by hijacking plasma albumin |
Gigi Yam | Changes in hemoglobin A1c levels after switching to bictegravir/emtricitibine/ tenofovir alafenamide fumarate |
Jessica Greger | Shot for shot: long-acting buprenorphine injections put a stop to opioid addiction |
Katherine Hong | The Effect of Antibody-Drug Conjugate to Reduce Systemic Toxicities Associated with Cancer Therapeutics |
Yoscar Ogando | Reticulocyte-driven Dosing of Erythropoiesis Stimulating Agents in Hemodialysis: Hitting the Hemoglobin Bull’s-eye |
Shahrier Hossain | Light at the end of the tunnel: elucidating Epogen dosing |
Stacy Yi | Outcomes of Staphylococcus aureus infection in critically ill children: does vancomycin trough really matter? |